Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - International Distributions Services Plc
-
StepStone Group to Present at the Morgan Stanley US Financials, Payments & CRE Conference
-
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
-
CARGO Therapeutics to Participate in Upcoming Investor Conferences
-
Longeveron® to Attend BIO International Convention 2024
-
StepStone Group to Present at the Morgan Stanley US Financials, Payments & CRE Conference
-
Form 8.3 - Hargreaves Lansdown Plc
-
Rachel Krauss Weise Appointed President of Research and Insights Division at Bastion
-
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
-
REPEAT – Large Protests This Week Across Ontario in Response to Ford Government’s Health Care Privatization & Closures of Local Hospitals
-
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
-
ParaZero Received a Purchase Order for its Advanced Safety Systems for UAE-based Manufacturer of Heavy-Lift Cargo Drones
-
Azincourt Energy Completes East Preston Winter Drill Program, Athabasca Basin, Saskatchewam
-
CHAR Tech Announces Production Run of 500 Tonnes of Pelletized Biocarbon at Thorold Facility
-
Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event
-
CMG Announces Appointment of Dave Montana as VP, Global Sales
-
Skyharbour’s Partner Azincourt Completes Winter Drill Program at East Preston Uranium Project
-
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia (AML)
-
GTT Names New Channel Chief
-
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
-
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
-
PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer
-
BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology
-
Marotta Controls Earns Exceptional Small Business Performance Award from Lockheed Martin for the Second Consecutive Year
-
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
-
Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
-
Utica University Selects ABM to Transform Campus-wide Facilities Management
-
DLH Announces Participation in Upcoming Events
-
Enphase Energy Launches IQ Battery 5P in Mexico
-
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility
-
Aummune’s Poster at ASCO 2024 to Highlight Ongoing Phase 1 Trial for AM003
-
Avalyn to Participate in Jefferies Global Healthcare Conference
-
ceτi AI Receives $2 Million Worth of H100 GPUs at T3 Data Center
-
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
-
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
-
Lilium Jet to Take Flight in the French Riviera in 2026
-
Ihsan Essaid Appointed Chief Financial Officer of QXO
-
Solowin Announces Strategic Partnership with MaiCapital to Expand Virtual Asset Allocation Opportunities
-
Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities
-
Foresight Announces First Quarter 2024 Financial Results
-
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
-
Kandi Shines at Thailand Golf Cart Expo, Expands in Southeast Asia
-
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
-
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
-
NEVADA CANYON SIGNS LAPON CANYON ROYALTY AGREEMENT
-
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
-
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
-
iLearningEngines Expects to Join the Russell 3000® Index
-
Cerro de Pasco Resources is Granted a Long-Awaited Land Easement for its Quiulacocha Project, Peru

